Nanozyme‐based Clusterphene for Enhanced Electrically Catalytic Cancer Therapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Zhengya Yue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Innovative Research in Synthetic Chemistry and Resource Utilization, College of Chemistry, Chemical Engineering and Resource Utilization, …. Hauptthemen laut MEDLINE: Hydrogen Peroxide, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province, Interdisciplinary Research Foundation of HIT.
Abstract (Originalsprache)
Nanozyme mediated catalytic therapy is an attractive strategy for cancer therapy. However, the nanozymes are tended to assemble into 3D architectures, resulting in poor catalytic efficiency for therapy. This study designs the assembly of nanozymes and natural enzymes into the layered structures featuring hexagonal pores as nanozyme clusterphene and investigates their catalytic therapy with the assistance of electric field. The nanozyme‐based clusterphene consists of polyoxometalate (POM) and natural glucose oxidase (GOx), named POMG‐based clusterphene, which facilitate multi‐enzyme activities including peroxidase (POD), catalase (CAT), and glutathione oxidase (GPx). The highly ordered layers with hexagonal pores of POMG units significantly improve the peroxidase‐like (POD‐like) activity of the nanozyme and thus the sustained production of reactive oxygen species (ROS). At the same time, GOx can increase endogenous H 2 O 2 and produce gluconic acid while consuming glucose, the nutrient of tumor cell growth. The results indicate that the POD‐like activity of POMG‐based clusterphene increase approximately sevenfold under electrical stimulation compared with Nd‐substituted keggin type POM cluster (NdPW 11 ). The experiments both in vitro and in vivo show that the proposed POMG‐based clusterphene mediated cascade catalytic therapy is capable of efficient tumor inhibiting and preventing tumor proliferation in tumor‐bearing mice model, promising as an excellent candidate for catalytic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Innovative Research in Synthetic Chemistry and Resource Utilization, College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestry University, Harbin, 150040, China.
- School of Medicine and Health, Harbin Institute of Technology, Harbin, China.
- State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin, 150080, China.
- Key Laboratory of Microsystems and Microstructures Manufacturing (Ministry of Education), Harbin Insti-tute of Technology, Harbin, China.
ORCID-Profile: Zhiguang Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
- Interdisciplinary Research Foundation of HIT
- State Key Laboratory of Robotics
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Yue, Z., Li, J., Tang, M., Sun, T., Chen, C., & Wu, Z. (2024). Nanozyme‐based Clusterphene for Enhanced Electrically Catalytic Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303222
Vancouver
Yue Z, Li J, Tang M, Sun T, Chen C, Wu Z. Nanozyme‐based Clusterphene for Enhanced Electrically Catalytic Cancer Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303222
BibTeX
@article{Yue2024,
author = {Yue, Zhengya and Li, Jialun and Tang, Minglu and Sun, Tiedong and Chen, Chunxia and Wu, Zhiguang},
title = {Nanozyme‐based Clusterphene for Enhanced Electrically Catalytic Cancer Therapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303222}
}
EUVIMED